InvestorsHub Logo

H2R

05/11/22 2:51 PM

#485 RE: thermo #484

Thank you, Thermo.

Priority review would be a plus :)

I may be getting monies on a company liquidity event here at my work. depending on the timing of the event and PPS at the time, I'm thinking of investing more in OTLK. Your thoughts are greatly appreciated!

Best of luck with your investments.

goforthebet

05/13/22 8:15 AM

#486 RE: thermo #484

any thoughts on the numbers?? thanks

Outlook Therapeutics GAAP EPS of -$0.09 misses by $0.03

May 13, 2022 8:06 AM ETOutlook Therapeutics, Inc. (OTLK)By: Deepa Sarvaiya, SA News Editor

Outlook Therapeutics press release (NASDAQ:OTLK): Q2 GAAP EPS of -$0.09 misses by $0.03.

At March 31, 2022, Outlook Therapeutics had cash and cash equivalents of $58.4 million, compared to $70.2 million at December 31, 2021.